CSBRChampions Oncology, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 13828
Ticker: CSBR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1994-10-31
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: CSBR

Detail

Enriched 2026-08-14 20:47

Market cap: $68,773,166.55
Shares outstanding (class): 13,893,569
Shares outstanding (weighted): 13,893,569
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 214
Location: BALTIMORE, MD
Homepage: https://www.championsoncology.com
Description: Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $1.90M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$1.32M	0.00%	229,971 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$362.4K	0.00%	63,022 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$129.7K	0.01%	22,550 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$37.5K	0.00%	6,527 NS	FIGI
Small Cap Core Fund Northern Funds	—	$28.1K	0.01%	4,883 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$10.1K	0.01%	1,755 NS	FIGI
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$7.6K	0.00%	1,317 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$5.3K	0.00%	915 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERCSBR
FIGI_COMPOSITEBBG000BYGPJ9
FIGI_SHARE_CLASSBBG001S5YHT9
CIK0000771856
ISINUS15870P3073
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Champions Oncology is a biotech company developing oncology solutions, matching the SIC biological products classification.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.